141 related articles for article (PubMed ID: 38401438)
1. Glutathione degradable manganese-doped polydopamine nanoparticles for photothermal therapy and cGAS-STING activated immunotherapy of lung tumor.
Lin H; Jiang C; Wang B; Wang Y; Shangguan Z; Wu Y; Wang X; Huang Y; Wang L; Chen P; Li X; Zhong Z; Wu S
J Colloid Interface Sci; 2024 Jun; 663():167-176. PubMed ID: 38401438
[TBL] [Abstract][Full Text] [Related]
2. Integrated manganese (III)-doped nanosystem for optimizing photothermal ablation: Amplifying hyperthermia-induced STING pathway and enhancing antitumor immunity.
Xia J; Wang L; Shen T; Li P; Zhu P; Xie S; Chen Z; Zhou F; Zhang J; Ling J; Liu X; Yu H; Sun J
Acta Biomater; 2023 Jan; 155():601-617. PubMed ID: 36400350
[TBL] [Abstract][Full Text] [Related]
3. Responsive manganese-based nanoplatform amplifying cGAS-STING activation for immunotherapy.
He Q; Zheng R; Ma J; Zhao L; Shi Y; Qiu J
Biomater Res; 2023 Apr; 27(1):29. PubMed ID: 37061706
[TBL] [Abstract][Full Text] [Related]
4. Manganese-containing polydopamine nanoparticles as theranostic agents for magnetic resonance imaging and photothermal/chemodynamic combined ferroptosis therapy treating gastric cancer.
Chen Z; Li Z; Li C; Huang H; Ren Y; Li Z; Hu Y; Guo W
Drug Deliv; 2022 Dec; 29(1):1201-1211. PubMed ID: 35403518
[TBL] [Abstract][Full Text] [Related]
5. Polydopamine Nanostructure-Enhanced Water Interaction with pH-Responsive Manganese Sulfide Nanoclusters for Tumor Magnetic Resonance Contrast Enhancement and Synergistic Ferroptosis-Photothermal Therapy.
Ma G; Zhang X; Zhao K; Zhang S; Ren K; Mu M; Wang C; Wang X; Liu H; Dong J; Sun X
ACS Nano; 2024 Jan; 18(4):3369-3381. PubMed ID: 38251846
[TBL] [Abstract][Full Text] [Related]
6. Photothermal nanozymes to self-augment combination cancer therapy by dual-glutathione depletion and hyperthermia/acidity-activated hydroxyl radical generation.
Wang TH; Shen MY; Yeh NT; Chen YH; Hsu TC; Chin HY; Wu YT; Tzang BS; Chiang WH
J Colloid Interface Sci; 2023 Nov; 650(Pt B):1698-1714. PubMed ID: 37499626
[TBL] [Abstract][Full Text] [Related]
7. H
Xiao Z; Zuo W; Chen L; Wu L; Liu N; Liu J; Jin Q; Zhao Y; Zhu X
ACS Appl Mater Interfaces; 2021 Sep; 13(37):43925-43936. PubMed ID: 34499485
[TBL] [Abstract][Full Text] [Related]
8. Glucose-responsive enzymatic biomimetic nanodots for H
Xu Y; Bian J; Liu X; Qian Z; Sun M; Zhang C; Pan R; Li Q; Sun C; Lin B; Peng K; Lu N; Yao X; Fan W
Acta Biomater; 2023 Dec; 172():441-453. PubMed ID: 37802309
[TBL] [Abstract][Full Text] [Related]
9. Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence.
Li M; Guo R; Wei J; Deng M; Li J; Tao Y; Li M; He Q
Acta Biomater; 2021 Dec; 136():546-557. PubMed ID: 34536603
[TBL] [Abstract][Full Text] [Related]
10. Manganese-enriched photonic/catalytic nanomedicine augments synergistic anti-TNBC photothermal/nanocatalytic/immuno-therapy via activating cGAS-STING pathway.
Zheng Y; Chen J; Song XR; Chang MQ; Feng W; Huang H; Jia CX; Ding L; Chen Y; Wu R
Biomaterials; 2023 Feb; 293():121988. PubMed ID: 36580716
[TBL] [Abstract][Full Text] [Related]
11. Tumor targeting and penetrating biomimetic mesoporous polydopamine nanoparticles facilitate photothermal killing and autophagy blocking for synergistic tumor ablation.
Huang X; Chen L; Lin Y; Tou KI; Cai H; Jin H; Lin W; Zhang J; Cai J; Zhou H; Pi J
Acta Biomater; 2021 Dec; 136():456-472. PubMed ID: 34562660
[TBL] [Abstract][Full Text] [Related]
12. Ultrasmall Gold-Coated Mesoporous Polydopamine Nanoprobe to Enhance Chemodynamic Therapy by Self-Supplying H
Wang Z; Shi Y; Shi Y; Zhang J; Hao R; Zhang G; Zeng L
ACS Appl Mater Interfaces; 2022 Dec; 14(49):54478-54487. PubMed ID: 36448730
[TBL] [Abstract][Full Text] [Related]
13. Combining photothermal therapy and immunotherapy against melanoma by polydopamine-coated Al
Chen W; Qin M; Chen X; Wang Q; Zhang Z; Sun X
Theranostics; 2018; 8(8):2229-2241. PubMed ID: 29721075
[TBL] [Abstract][Full Text] [Related]
14. Copperphosphotungstate Doped Polyanilines Nanorods for GSH-Depletion Enhanced Chemodynamic/NIR-II Photothermal Synergistic Therapy.
Ye S; Xiao H; Chen J; Zhang D; Qi L; Peng T; Gao Y; Zhang Q; Qu J; Wang L; Liu R
Int J Nanomedicine; 2023; 18():1245-1257. PubMed ID: 36937549
[TBL] [Abstract][Full Text] [Related]
15. Glucose/Glutathione Co-triggered Tumor Hypoxia Relief and Chemodynamic Therapy to Enhance Photothermal Therapy in Bladder Cancer.
Chen WH; Yu KJ; Jhou JW; Pang HH; Weng WH; Lin WS; Yang HW
ACS Appl Bio Mater; 2021 Oct; 4(10):7485-7496. PubMed ID: 35006706
[TBL] [Abstract][Full Text] [Related]
16. A mesoporous polydopamine nanoparticle enables highly efficient manganese encapsulation for enhanced MRI-guided photothermal therapy.
Wu Y; Huang Y; Tu C; Wu F; Tong G; Su Y; Xu L; Zhang X; Xiong S; Zhu X
Nanoscale; 2021 Apr; 13(13):6439-6446. PubMed ID: 33885524
[TBL] [Abstract][Full Text] [Related]
17. Fe(III)-Chelated Polydopamine Nanoparticles for Synergistic Tumor Therapies of Enhanced Photothermal Ablation and Antitumor Immune Activation.
Xu N; Hu A; Pu X; Li J; Wang X; Wang J; Huang Z; Liao X; Yin G
ACS Appl Mater Interfaces; 2022 Apr; 14(14):15894-15910. PubMed ID: 35357136
[TBL] [Abstract][Full Text] [Related]
18. MnCO
Lee KK; Lee JH; Lee SC; Lee CS
Theranostics; 2022; 12(15):6762-6778. PubMed ID: 36185599
[No Abstract] [Full Text] [Related]
19. Cu-Chelated polydopamine nanoparticles as a photothermal medium and "immunogenic cell death" inducer for combined tumor therapy.
Xu N; Hu A; Pu X; Wang J; Liao X; Huang Z; Yin G
J Mater Chem B; 2022 Apr; 10(16):3104-3118. PubMed ID: 35348176
[TBL] [Abstract][Full Text] [Related]
20. Targeted polydopamine nanoparticles enable photoacoustic imaging guided chemo-photothermal synergistic therapy of tumor.
Li Y; Jiang C; Zhang D; Wang Y; Ren X; Ai K; Chen X; Lu L
Acta Biomater; 2017 Jan; 47():124-134. PubMed ID: 27721008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
